NTP42

CAS No. 2055599-51-2

NTP42( —— )

Catalog No. M23921 CAS No. 2055599-51-2

NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 154 In Stock
2MG 79 In Stock
5MG 136 In Stock
10MG 215 In Stock
25MG 364 In Stock
50MG 529 In Stock
100MG 759 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NTP42
  • Note
    Research use only, not for human use.
  • Brief Description
    NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM)
  • Description
    NTP42 is an antagonist of thromboxane A2 (TXA2) receptor(IC50 of 3.278 nM) .
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male Wistar-Kyoto rats Dosage:0.25 mg/kg BID Administration:28-day drug treatment was initiated within 24 h post-MCT (60 mg/kg)Result:Reduced the MCT-induced PAH, including mPAP and RSVP.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    TXA2R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2055599-51-2
  • Formula Weight
    515.53
  • Molecular Formula
    C25H23F2N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30mg/mL (58.19 mM; Need ultrasonic)
  • SMILES
    CC(C)(C)NC(NS(c(cc(cc1)C#N)c1Oc1cc(-c(cc2)ccc2OC(F)F)ccc1)(=O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.B. Therese KINSELLA, et al. Thromboxane receptor antagonists. WO2016203314A1.
molnova catalog
related products
  • MCC 555

    MCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) is an activating ligand of PPARγ with EC50 of 8 uM.

  • AZD2461

    AZD2461 is a novel PARP inhibitor.

  • (±)4-HDHA

    (±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.